
ASML is presented as a more favorable investment than Texas Instruments due to its monopoly in EUV lithography critical for advanced chip manufacturing, projecting a 15% revenue increase for 2025, and a lower forward P/E ratio of 26.10X compared to TXN's 32.14X. While TXN's industrial and automotive segments show steady growth, its slower overall revenue growth (11%) and EPS increase (6.7%) lag behind ASML, leading to a Zacks Rank #2 (Buy) for ASML versus a Zacks Rank #3 (Hold) for TXN.
ASML Holding (ASML) presents a more compelling investment outlook compared to Texas Instruments (TXN), primarily due to its monopolistic position in supplying essential extreme ultraviolet (EUV) and next-generation High-NA EUV lithography machines, critical for manufacturing advanced chips for AI, mobile devices, and data centers. This strategic advantage is reflected in ASML's strong financial performance, with Q1 2025 revenue growth of 46% and a 93% surge in earnings per share, and an anticipated 15% revenue increase for the full year 2025. The Zacks Consensus Estimate further supports this, projecting 21.5% sales and 30.5% EPS growth for ASML in 2025. In contrast, Texas Instruments, which focuses on analog and embedded chips, reported more modest Q1 2025 revenue growth of 11% and an EPS increase of 6.7%, with Zacks Consensus Estimates for 2025 indicating 10.6% sales and 6.7% EPS growth. While TXN's industrial and automotive segments (70% of Q1 revenue) show resilience, its personal electronics segment is experiencing a significant downturn. Valuation also favors ASML, which trades at a forward 12-month P/E of 26.10X, below its three-year median and notably lower than TXN's P/E of 32.14X, which is above its median and harder to justify given its slower growth. ASML's year-to-date share performance of +7.7% also outpaces TXN's +0.5%. A significant consideration for ASML is its exposure to China, which accounted for 41% of its 2024 shipments, and potential impacts from U.S. export restrictions, although strong demand from other regions may mitigate this risk. ASML holds a Zacks Rank #2 (Buy), while TXN is rated #3 (Hold).
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment